Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sublingual and oral immunotherapy.

Giorgio Walter Canonica1, Enrico Compalati, Federica Fumagalli

  • 1Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Padiglione Maragliano, L.go R. Benzi 10, Genoa 16132, Italy. gcanonica@qubisoft.it

Immunology and Allergy Clinics of North America
|October 12, 2004
PubMed
Summary

Sublingual immunotherapy (SLIT) offers a safe and effective alternative for treating respiratory allergies, similar to the established subcutaneous method. While SLIT shows lasting benefits, further research is needed to optimize dosage and confirm its asthma prevention capabilities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Allergy·2025
Same author

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Allergy·2025
Same author

Carbamylated monomeric allergoids for sublingual immunotherapy in pediatric respiratory allergies.

Asia Pacific allergy·2025
Same author

Correction: Clinical characteristics, use and switch of drugs for obstructive airway diseases among patients with COPD experiencing an exacerbation: a retrospective analysis of Italian administrative healthcare data.

BMC pulmonary medicine·2024
Same author

A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma.

The World Allergy Organization journal·2024

Area of Science:

  • Allergy and Immunology
  • Pharmacology

Background:

  • Sublingual immunotherapy (SLIT) is an established treatment for respiratory allergies.
  • The pure oral route has been discontinued due to insufficient efficacy.
  • SLIT presents an optimal safety profile in both adult and pediatric populations.

Purpose of the Study:

  • To evaluate SLIT as a viable alternative to subcutaneous immunotherapy for respiratory allergies.
  • To highlight the safety and efficacy of SLIT.
  • To identify areas for further research, including optimal dosing and asthma prevention.

Main Methods:

  • Review of existing data on sublingual immunotherapy.
  • Comparison of SLIT with subcutaneous immunotherapy and the oral route.
  • Assessment of safety profiles and long-lasting effects.

Related Experiment Videos

Main Results:

  • SLIT demonstrates a viable alternative to subcutaneous immunotherapy for respiratory allergies.
  • SLIT has an optimal safety profile, proven in adults and children.
  • Long-lasting effects are evident with SLIT, though optimal dosage and asthma prevention require more investigation.

Conclusions:

  • Sublingual immunotherapy is a safe and effective treatment option for respiratory allergies.
  • Further studies are necessary to establish optimal dosing and the preventive role of SLIT in asthma management.